For citations:
Kopyltsov E.I., Vodolazskiy V.A., Skoraya M.V., Kozlov V.V. Effectiveness of combination of lenvatinib and pembrolizumab in first line therapy of metastatic renal cell carcinoma. Medical alphabet. 2022;(26):58-63. (In Russ.) https://doi.org/10.33667/2078-5631-2022-26-58-63
Email this article 